Literature DB >> 11891947

Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report.

Gerry F Funk1, Lucy Hynds Karnell, Robert A Robinson, Weining K Zhen, Douglas K Trask, Henry T Hoffman.   

Abstract

BACKGROUND: Oral cancer has been identified as a significant public health threat. Systematic evaluation of the impact of this disease on the US population is of great importance to health care providers and policy makers.
METHODS: This study used the National Cancer Data Base (NCDB) to evaluate associations between demographic and disease characteristics, treatment, and survival for patients with oral cavity cancer in the United States. Of patients diagnosed between 1985 and 1996, 58,976 were extracted from the NCDB. ANOVAs were performed on selected cross-tabulations, and relative survival was used to calculate outcome.
RESULTS: Median age of patients was 64.0 years. Men made up 60.2% of patients. Pathologic diagnosis was squamous cell carcinoma (SCC) in 86.3% of cases. Younger patients had a much higher frequency of non-SCC, and this was related to survival in these patients. African-Americans (independent of income), lower income patients, and patients with higher grade disease were seen more frequently with advanced-stage SCC. Five-year relative survival for SCC cases was lower for older patients, men, and African-Americans.
CONCLUSIONS: This study addressed many issues related to oral cancer that have been previously discussed in the literature. The demographic, site, stage, histologic, and survival data available for this large number of cases in the NCDB allowed an accurate characterization of the contemporary status of oral cancer in the United States. Copyright 2002 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11891947     DOI: 10.1002/hed.10004

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  93 in total

1.  S100A4 expression in xenograft tumors of human carcinoma cell lines is induced by the tumor microenvironment.

Authors:  Hilde Ljones Wetting; Elin Hadler-Olsen; Synnøve Magnussen; Oddveig Rikardsen; Sonja E Steigen; Elisabeth Sundkvist; Thrina Loennechen; Premasany Kanapathippillai; Hanne Kildalsen; Jan-Olof Winberg; Lars Uhlin-Hansen; Gunbjørg Svineng
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Squamous cell carcinoma of the oral tongue in the pediatric age group: a matched-pair analysis of survival.

Authors:  Luc G T Morris; Snehal G Patel; Jatin P Shah; Ian Ganly
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-07

3.  Squamous Cell Carcinoma of the Oral Tongue in Young Patients: Outcomes and Implications for Treatment.

Authors:  Narayana Subramaniam; Deepak Balasubramanian; Tsu-Hui Hubert Low; Sivakumar Vidhyadharan; Anjali Menon; Samskruthi Murthy; Krishnakumar Thankappan; Jonathan R Clark; Kan Gao; Subramania Iyer
Journal:  Indian J Surg Oncol       Date:  2020-02-22

Review 4.  Molecular mechanisms of head and neck cancer.

Authors:  Amit M Deshpande; David T Wong
Journal:  Expert Rev Anticancer Ther       Date:  2008-05       Impact factor: 4.512

5.  Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer.

Authors:  Liwei Bao; Michael A Gorin; Manchao Zhang; Alejandra C Ventura; William C Pomerantz; Sofia D Merajver; Theodoros N Teknos; Anna K Mapp; Quintin Pan
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

6.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

7.  Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma.

Authors:  Zhi Wang; Lu Jiang; Canhua Huang; Zhengyu Li; Lijuan Chen; Lantu Gou; Ping Chen; Aiping Tong; Minghai Tang; Feng Gao; Jun Shen; Yuanyuan Zhang; Jingping Bai; Min Zhou; Di Miao; Qianming Chen
Journal:  Mol Cell Proteomics       Date:  2008-05-04       Impact factor: 5.911

8.  Proton and phosphorous MR spectroscopy in squamous cell carcinomas of the head and neck.

Authors:  Sanjeev Chawla; Sungheon Kim; Laurie A Loevner; Harry Quon; Sumei Wang; Faith Mutale; Gregory Weinstein; Edward J Delikatny; Harish Poptani
Journal:  Acad Radiol       Date:  2009-07-15       Impact factor: 3.173

9.  Stromal impact on tumor growth and lymphangiogenesis in human carcinoma xenografts.

Authors:  Elin Hadler-Olsen; Hilde Ljones Wetting; Oddveig Rikardsen; Sonja E Steigen; Premasany Kanapathippillai; Reidar Grénman; Jan-Olof Winberg; Gunbjørg Svineng; Lars Uhlin-Hansen
Journal:  Virchows Arch       Date:  2010-10-03       Impact factor: 4.064

10.  Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.

Authors:  Emanuela Taioli; Camille Ragin; Xiao-Hong Wang; Jiangying Chen; Scott M Langevin; Ashley R Brown; Susanne M Gollin; Seymour Garte; Robert W Sobol
Journal:  BMC Cancer       Date:  2009-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.